Telomerase activity in human proliferative breast lesions

International Journal of Oncology

Volumn 12, Issue 3, 1998, Pages 641-648

  Poremba, Christopher ^a   Böcker, Werner ^a   Willenbring, Holger ^b   Schäfer, Karl Ludwig ^a   Otterbach, Friedrich ^a   Bürger, Horst ^a   Diallo, Raihanatou ^a   Dockhorn Dworniczak, Barbara ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Breast cancer; Cell proliferation; Laser fluorescence sequencer; Telomerase; Telomeric repeat amplification protocol

Indexed keywords

DNA; TELOMERASE;

ARTICLE; BREAST; BREAST CANCER; BREAST CARCINOMA; BREAST LESION; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FIBROADENOMA; FLUORESCENCE ANALYSIS; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TELOMERE;

EID: 0031931107     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.3.641     Document Type: Article

References (42)

1. Aldous WK and Grabill NR: A fluorescent method for detection of telomerase activity. Diagn Mol Pathol 6: 102-110, 1997.
2. Bednarek AK, Sahin A, Brenner AJ, Johnston DA and Aldaz CM: Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. Clin Cancer Res 3: 11-16, 1997.
3. Blackburn EH: Structure and function of telomeres. Nature 350: 569-573, 1991.
4. Böcker W, Bier B, Freytag G, et al: An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: normal breast and benign proliferative lesions. Virchows Arch A 421: 315-322, 1992.
5. Böcker W, Bier B, Freytag G, et al: An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: epitheliosis and ductal carcinoma in situ. Virchows Arch A 421: 323-330, 1992.
6. Clark GM, Osborne CK, Levin D, Wu F and Kim NW: Telomerase activity and survival of patients with node-positive breast cancer. J Natl Cancer Inst (In press).
7. Counter CM, Avilion AA, LeFeuvre CE, et al: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerasc activity. EMBO J 11: 1921-1929, 1992.
8. Counter CM, Hirte HW, Bacchetti S and Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900-2904, 1994.
9. De Lange T: Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 91: 2882-2885, 1994.
10. Deos PH and Norris HJ: Well-differentiated (tubular) carcinoma of the breast. A clinicopatholocic study of 145 pure and mixed cases. Am J Clin Pathol 78: 1-7, 1982.
11. Dockhorn-Dworniczak B, Schäfer KL, Dantcheva R, Blasius S, Winkelmann W, Strehl S, Burdach S, van Valen F, Jürgens H and Böcker W: Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumor. Virchows Arch 425: 107-112, 1994.
12. Dupont WD, Page DL, Pari FF, et al: Long-term risk of breast cancer in women with fibroadenoma. N Endl J Med 331: 10-15, 1994.
13. Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991.
14. Fiedler W, Dahse R, Schlichter A, Junker K, Kosmehl H, Ernst G, Schubert J and Claussen U: Telomerase activity and telomere length in different areas of renal cell carcinoma. Int J Oncol 9: 1227-1232, 1996.
15. Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
16. Healy KC: Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy. Oncol Res 7: 121-130, 1995.
17. Hiyama E, Gollahon L, Kataoka T, et al: Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122, 1996.
18. Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW and Yokoyama T: Telomerase activity in human intestine. Int J Oncol 9: 453-458, 1996.
19. Hiyama E, Hiyama K, Yokoyama T, et al: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1: 249-255, 1995.
20. Hiyama E, Yokoyama T, Tatsumoto N, et al: Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262, 1995.
21. Hiyama K, Hiyama E, Ishioka S, et al: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87: 895-902, 1995.
22. Holland R, Peterse JL, Millis RR, et al: Ductal carcinomas in situ: a proposal for a new classification. Semin Diagn Pathol 11: 167-180, 1994.
23. Holt SE, Aisner DL, Shay JW and Wright WE: Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci USA 94: 10687-10692, 1997.
24. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
25. Kobayashi T, Clodi K, Yang Y, Ruan S, Shiku H, Andreeff M, Shay JW and Zhang W: Inhibition of telomerase activity correlates with a decrease in the RNA component of telomerase during differentiation. Int J Oncol 11: 13-17, 1997.
26. Koerner FC and O'Connell JX: Fibroadenoma: morphological oberservations and a theory of pathogenesis. Pathol Annu 29: 1-19, 1994.
27. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529, 1989.
28. Muller M, Heine B, Heicappell R, Emrich T, Hummel M, Stein H and Miller K: Telomerase activity in bladder cancer, bladder washings and in urine. Int J Oncol 9: 1169-1173, 1996.
29. Noguchi S, Motomura K, Inaji H, Imaoka S and Koyama H: Clonal analysis of fibroadenoma and phylloides tumor of breast. Cancer Res 53:4071-4074, 1993.
30. Ohyashiki JH, Ohyashiki K, Sano T and Toyama K: Non-radioisotopic and semiquantitative procedure for terminal repeat amplification protocol. Jpn J Cancer Res 87: 329-331, 1996.
31. Piffko J, Bankfalvi A, Öfner D, Kusch F, Böcker W, Joos U and Schmid KW: In situ assessment of cell proliferation at the invasive front of oral squamous cell carcinomas. Virchows Arch 429: 229-234, 1996.
32. Poller DN, Silverstein MJ, Galea M, et al: Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification. Association between cellular proliferation and c-erbB2-expression. Mod Pathol 7: 257-262, 1994.
33. Rasmussen BB, Rose C and Christensen I: Prognostic factors in primary mucinous breast carcinoma. Am J Clin Pathol 87: 155-160, 1987.
34. Sharma HW, Sokoloski JA, Perez JU, et al: Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 92: 12343-12346, 1995.
35. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997.
36. Silverstein MJ, Poller DN, Waisman JR, et al: Prognostic classification of breast ductal carcinoma in situ. Lancet 345: 1154-1157, 1995.
37. Sommerfeld HJ, Meeker AK, Piatyszek MA, et al: Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56: 218-222, 1996.
38. Sugino T, Yoshida K, Bolodeoku J, et al: Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer (Pred Oncol) 69: 301-306, 1996.
39. Tsao JI, Zhao Y, Lukas J, Yang X, Shah A, Press M and Shibata D: Telomerase acitivity in nomal and neoplastic breast. Clin Cancer Res 3: 627-631, 1997.
40. Wright WE and Shay JW: The two-stage mechanism controlling cellular senescence and immortalization. Exp Geron 27: 383-389, 1992.
41. Wynford-Thomas D: Telomeres, p53 and cellular senescence. Oncol Res 8: 387-398, 1996.
42. Yashima K, Piatyszek MA, Saboorian HM, Virmani AK, Brown D, Shay JW and Gazdar AF: Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 50: 110-117, 1997.